Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 31, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 3, 2026
DirectorTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193210-26-000025
Filed / recorded
Sep 3, 2026, 1:03 AM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Jazz Pharmaceuticals plc
Issuer CIK
1232524
Ticker
JAZZ
Reporting person
Bruce C Cozadd
Relationship
Director
Security
Ordinary Shares
Table
Non-derivative (Table I)
Transaction date
Aug 31, 2026
Transaction code
F
Shares / units
10
Price per share
$244.06
Acquired / disposed
Disposed (D)
Shares owned after
359,084
Ownership form
Direct
Amendment
No
Footnotes from the filing
Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Includes the November 3, 2025 disposition of 3,193 shares for the withholding of restricted stock units by the Issuer to satisfy FICA taxes arising from the Reporting Person being retirement eligible which was previously inadvertently not reported; not an open market transaction.